Colcrys for Acute Gout Fayetteville NC

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

Sears Eye Care - Cross Creek Mall
(910) 292-9979
4940 Morganton Rd
Fayetteville, NC

Data Provided by:
All Pets Hospital for Animals
(910) 323-5845
118 Cedar Creek Rd
Fayetteville, NC

Data Provided by:
A Healthy Back
(910) 390-0994
1248 Ft. Bragg Road
Fayetteville, NC

Data Provided by:
Professional Eye Care Optometry
(910) 644-0941
3701 S Main
Hope Mills, NC

Data Provided by:
Corey W Gilliland, DO
(910) 286-6917
Fayetteville, NC
Specialties
General Practice, Aerospace Medicine
Gender
Male
Education
Medical School: Univ Of Hlth Sci, Coll Of Osteo Med, Kansas City Mo 64124
Graduation Year: 1999

Data Provided by:
Cape Fear Animal Hospital
(910) 867-0103
3309 Bragg Blvd
Fayetteville, NC

Data Provided by:
Seventy First Animal Hospital
(910) 487-5070
7103 Raeford Road
Fayetteville, NC

Data Provided by:
Cross Creek Animal Hospital
(910) 868-1164
2147 Skibo Rd.
Fayetteville, NC

Data Provided by:
Shobha R Gali
(910) 486-6818
1248 Fort Bragg Rd
Fayetteville, NC
Specialty
Family Practice

Data Provided by:
David D Stewart
(910) 484-1156
114 Broadfoot Ave
Fayetteville, NC
Specialty
Internal Medicine

Data Provided by:
Data Provided by:

Colcrys for Acute Gout

Provided By:

Colcrys has been approved by the U.S. Food and Drug Administration to treat acute gout and familial Mediterranean fever (FMF), two inflammatory disorders. The drug's active ingredient, colchicine, is derived from the dried seeds of the autumn crocus plant.

In a news release, the agency said colchicine has been used as a remedy to treat acute gout flares "for many years," despite that it hadn't been FDA approved. The agency said it was in the midst of a program to bring other similarly unapproved products under its regulatory authority.

A dosing study required for approval led the agency to recommend a lower dosing regimen for Colcrys that had been commonly prescribed, the news release said. This was designed to prevent gastrointestinal problems.

The FDA said it was alerting healthcare professionals of the lower dosing schedule and also warning that the drug had the potential for severe interactions with other medications.

FMF, common in Mediterranean nations but less so in the United States, has symptoms including fever, arthritis, and inflammation of the lining of the lungs and abdomen. Colcrys is now the first drug that's been FDA-approved to treat FMF, the agency said.

The drug is produced by Philadelphia-based Mutual Pharmaceutical Company Inc.

More information

The FDA has more about this medication's approval.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com